- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic kidney disease associated pruritus
- Meeting Date: March 2023
- Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 959KB)
- Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 364KB)
Difelikefalin – March 2023
Difelikefalin: Solution for I.V. injection 50 mcg in 1 mL vial; Korsuva®
Last updated
14 July 2023